Davis's Drug Guide
tositumomab (I 131 tositumomab)
General
Genetic Implications:
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
to-si-too-mo-mab
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Bexxar
Ther. Class.
Pharm. Class.
monoclonal antibodies
(radiolabled monoclonal antibodies)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Tositumomab (I 131 Tositumomab)." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109615/all/tositumomab__I_131_tositumomab_.
Vallerand AHA, Sanoski CAC, Quiring CC. Tositumomab (I 131 tositumomab). Davis's Drug Guide. F.A. Davis Company; 2024. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109615/all/tositumomab__I_131_tositumomab_. Accessed December 28, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Tositumomab (I 131 tositumomab). In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109615/all/tositumomab__I_131_tositumomab_
Vallerand AHA, Sanoski CAC, Quiring CC. Tositumomab (I 131 Tositumomab) [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 December 28]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109615/all/tositumomab__I_131_tositumomab_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - tositumomab (I 131 tositumomab)
ID - 109615
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109615/all/tositumomab__I_131_tositumomab_
PB - F.A. Davis Company
ET - 19
DB - Pediatrics Central
DP - Unbound Medicine
ER -
